Hotline:
+ 49 (0) 2204 2918806

Market studies for category Healthcare

Items 1 to 10 of 117 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 12
  1. Net price*
    Year
  2. $1,995.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Healthcare, Regulatory and Reimbursement Landscape - Colombia

    GlobalData
    169 pages
    Introduction Industry analysis specialist GlobalData has released its new report, “Healthcare, Regulatory and Reimbursement Landscape - Colombia”. An essential source of information and analysis on the Colombian healthcare, regulatory, and reimbursement landscape, this report identifies the key trends in the healthcare market, and pro
    Englisch | Report | SKU: 330255
  3. $6,995.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Brivaracetam (Epilepsy) - Forecast and Market Analysis to 2022

    GlobalData
    67 pages
    Introduction GlobalData has released its new PharmaPoint Drug Evaluation report, “Brivaracetam (Epilepsy) - Forecast and Market Analysis to 2022”. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure red
    Englisch | Report | SKU: 330451
  4. $2,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Atrial Flutter Global Clinical Trials Review, H1, 2013

    GlobalData
    210 pages
    Introduction GlobalData's clinical trial report, “Atrial Flutter Global Clinical Trials Review, H1, 2013" provides data on the Atrial Flutter clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Atrial Flutter. It includes an overview of the trial numbers and their recruitment s
    Englisch | Report | SKU: 330315
  5. $4,995.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    PharmaPoint: HIV - Spain Drug Forecast and Market Analysis to 2022

    GlobalData
    149 pages
    Introduction GlobalData has released its new Country report, “PharmaPoint: HIV - Spain Drug Forecast and Market Analysis to 2022”. Human Immunodeficiency Virus (HIV), the causative agent of AIDS, has claimed millions of lives since its emergence. However, the advent of antiretroviral therapy (ART) has transformed the face of HIV/AIDS
    Englisch | Report | SKU: 330270
  6. $2,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Gestational Diabetes Global Clinical Trials Review, H1, 2013

    GlobalData
    84 pages
    Introduction GlobalData's clinical trial report, “Gestational Diabetes Global Clinical Trials Review, H1, 2013" provides data on the Gestational Diabetes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gestational Diabetes. It includes an overview of the trial numbers and t
    Englisch | Report | SKU: 330456
  7. $1,995.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Healthcare, Regulatory and Reimbursement Landscape - Jordan

    GlobalData
    133 pages
    Introduction GlobalData, the industry analysis specialist, has released its new report, “Healthcare, Regulatory and Reimbursement Landscape - Jordan”. The report is an essential source of information and provides an analysis of the healthcare, regulatory and reimbursement landscape of Jordan. The report identifies the key trends in th
    Englisch | Report | SKU: 329151
  8. $2,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Thromboembolism Global Clinical Trials Review, H1, 2013

    GlobalData
    139 pages
    Introduction GlobalData's clinical trial report, “Thromboembolism Global Clinical Trials Review, H1, 2013" provides data on the Thromboembolism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Thromboembolism. It includes an overview of the trial numbers and their recruitmen
    Englisch | Report | SKU: 330320
  9. $4,995.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022

    GlobalData
    130 pages
    Introduction GlobalData has released its new Country report, “PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022”. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reduction. Th
    Englisch | Report | SKU: 330281
  10. $2,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2013

    GlobalData
    187 pages
    Introduction GlobalData's clinical trial report, “Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2013" provides data on the Hidradenitis Suppurativa clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hidradenitis Suppurativa. It includes an overview of the trial n
    Englisch | Report | SKU: 330461
  11. $2,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Filariasis Global Clinical Trials Review, H1, 2013

    GlobalData
    62 pages
    Introduction GlobalData's clinical trial report, “Filariasis Global Clinical Trials Review, H1, 2013" provides data on the Filariasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Filariasis. It includes an overview of the trial numbers and their recruitment status as per
    Englisch | Report | SKU: 329577

Items 1 to 10 of 117 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 12